The DO

Policy update: The AOA supports reclassification of cannabis as a Schedule II Drug

By The DO

08.08.18

The reclassification would facilitate advancement in clinical, public health, patient safety and health policy research, according to a resolution passed at the 2018 AOA House of Delegates.